• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食物引起的普萘洛尔生物利用度增加——与蛋白质的关系及对代谢物的影响

Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolites.

作者信息

Walle T, Fagan T C, Walle U K, Oexmann M J, Conradi E C, Gaffney T E

出版信息

Clin Pharmacol Ther. 1981 Dec;30(6):790-5. doi: 10.1038/clpt.1981.239.

DOI:10.1038/clpt.1981.239
PMID:7307427
Abstract

The influence of a meal on the disposition and metabolism of oral propranolol was examined in six normal subjects. The meal induced a mean 53% increase in propranolol bioavailability (range 2% to 92%; P less than 0.01) without affecting time to maximum concentration, half-life, or the amount of unchanges drug in urine. There was no effect on the plasma concentrations of 4-hydroxypropranolol or four other metabolites. The increased bioavailability was linearly related to the protein content of the meal (r = 0.884, P less than 0.02) above a threshold content of about 7 gm.

摘要

在6名正常受试者中研究了进餐对口服普萘洛尔处置和代谢的影响。进餐使普萘洛尔的生物利用度平均增加53%(范围为2%至92%;P<0.01),而不影响达峰时间、半衰期或尿中未变化药物的量。对4-羟基普萘洛尔或其他四种代谢物的血浆浓度没有影响。生物利用度的增加与进餐的蛋白质含量呈线性相关(r = 0.884,P<0.02),阈值含量约为7克。

相似文献

1
Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolites.食物引起的普萘洛尔生物利用度增加——与蛋白质的关系及对代谢物的影响
Clin Pharmacol Ther. 1981 Dec;30(6):790-5. doi: 10.1038/clpt.1981.239.
2
Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.食物对普萘洛尔全身清除率和口服清除率的影响:对血流假说的支持。
Clin Pharmacol Ther. 1986 Oct;40(4):408-14. doi: 10.1038/clpt.1986.198.
3
Decreased absorption as a possible cause for the lower bioavailability of a sustained-release propranolol.吸收减少可能是缓释普萘洛尔生物利用度较低的一个原因。
J Pharm Sci. 1990 Mar;79(3):212-5. doi: 10.1002/jps.2600790306.
4
Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet.与高碳水化合物饮食相比,高蛋白饮食使普萘洛尔和茶碱的清除率增加。
Clin Pharmacol Ther. 1987 Apr;41(4):402-6. doi: 10.1038/clpt.1987.48.
5
Effect of carbohydrates on estimated hepatic blood flow.碳水化合物对估计肝血流量的影响。
Clin Pharmacol Ther. 1984 May;35(5):660-5. doi: 10.1038/clpt.1984.91.
6
Kinetic and clinical observations in cyanotic children on propranolol therapy.对接受普萘洛尔治疗的青紫型儿童的动力学和临床观察。
Clin Pharmacol Ther. 1980 Dec;28(6):743-50. doi: 10.1038/clpt.1980.230.
7
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.食物对肝血流量的影响:对“食物效应”现象的启示
Clin Pharmacol Ther. 1983 Sep;34(3):316-23. doi: 10.1038/clpt.1983.174.
8
No stereoselective first-pass hepatic extraction of propranolol.普萘洛尔不存在肝脏首过效应的立体选择性提取。
Clin Pharmacol Ther. 1981 Sep;30(3):291-6. doi: 10.1038/clpt.1981.162.
9
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol.单次及长期服用普萘洛尔后的4-羟基普萘洛尔及其葡糖醛酸苷。
Clin Pharmacol Ther. 1980 Jan;27(1):22-31. doi: 10.1038/clpt.1980.4.
10
Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.犬长期给药期间普萘洛尔生物利用度的立体选择性增加。
J Pharmacol Exp Ther. 1983 Nov;227(2):360-4.

引用本文的文献

1
Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology.心内科中β-肾上腺素能阻滞剂的药代动力学变异性。
Pharmacol Res Perspect. 2019 Jul 12;7(4):e00496. doi: 10.1002/prp2.496. eCollection 2019 Aug.
2
Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs.将时变的餐后内脏血流增加纳入到 PBPK 模型中,以预测食物对口服高提取药物的药代动力学的影响。
AAPS J. 2017 Jul;19(4):1205-1217. doi: 10.1208/s12248-017-0099-z. Epub 2017 May 19.
3
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.
肿瘤学中药物的重新利用(ReDO)——普萘洛尔作为一种抗癌药物。
Ecancermedicalscience. 2016 Oct 12;10:680. doi: 10.3332/ecancer.2016.680. eCollection 2016.
4
Trauma reactivation under the influence of propranolol: an examination of clinical predictors.普萘洛尔影响下的创伤再激活:临床预测因子的考察。
Eur J Psychotraumatol. 2012;3. doi: 10.3402/ejpt.v3i0.15470. Epub 2012 Feb 14.
5
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.PKQuest:一种基于生理学的通用药代动力学模型。普萘洛尔的介绍与应用
BMC Clin Pharmacol. 2002 Aug 15;2:5. doi: 10.1186/1472-6904-2-5.
6
Effects of food on the pharmacokinetics of methylphenidate.食物对哌甲酯药代动力学的影响。
Pharm Res. 2001 Aug;18(8):1185-9. doi: 10.1023/a:1010987212724.
7
Influence of diet and nutritional status on drug metabolism.饮食和营养状况对药物代谢的影响。
Clin Pharmacokinet. 1996 Jul;31(1):47-64. doi: 10.2165/00003088-199631010-00004.
8
Individual variation in first-pass metabolism.首过代谢的个体差异。
Clin Pharmacokinet. 1993 Oct;25(4):300-28. doi: 10.2165/00003088-199325040-00005.
9
Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions.与肼屈嗪或食物合用时,缓释普萘洛尔的口服稳定性:有证据表明底物递送速率是系统性前药物相互作用的一个决定因素。
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):45S-50S. doi: 10.1111/j.1365-2125.1984.tb02427.x.
10
First-pass elimination. Basic concepts and clinical consequences.首过消除。基本概念及临床后果。
Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001.